Cited by Crossref (13)

  1. Yoo-Bin Seo. Strategies for Long-Term Weight Loss and Maintenance. Korean J Fam Pract 2023;13:128
    https://doi.org/10.21215/kjfp.2023.13.3.128
  2. Koutaro Yokote, Riku Ota, Shogo Wada, Hiroyuki Matsuda, Ronald Filomeno. Clinical Efficacy and Safety of Anti-Obesity Medications Among Adult East Asian People with Obesity: A Systematic Literature Review and Indirect Treatment Comparison. Adv Ther 2024;41:3452
    https://doi.org/10.1007/s12325-024-02941-7
  3. Gabriel Cubillos-Valencia, Neidalis Vasquez, Andrés-Miguel Ortegón-Pulido, Diego Rivera-Porras, Valmore Bermúdez. Multifrequency low-level laser-assisted lipolysis outcomes. A dataset from 101 patients. Data in Brief 2024;57:111038
    https://doi.org/10.1016/j.dib.2024.111038
  4. Vincent Cheng, Kamran Samakar, Adrian B. Dobrowolsky, James D. Nguyen, Stuart A. Abel, Andrea Pakula, Andrew Bernard, Matthew J. Martin. Common postbariatric surgery emergencies for the acute care surgeon: What you need to know. J Trauma Acute Care Surg 2023;95:817
    https://doi.org/10.1097/TA.0000000000004125
  5. Xin‐Hui Pan, Bryan Tan, Yip Han Chin, Ethan Cheng Zhe Lee, Gwyneth Kong, Bryan Chong, Martin Kueh, Chin Meng Khoo, Anurag Mehta, Priyanka Majety, Gowtham R. Grandhi, Georgios K. Dimitriadis, Roger Foo, Nicholas W. S. Chew, Carel W. Le Roux, Mamas A. Mamas, Mark Y. Chan. Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis. Obesity 2024;32:840
    https://doi.org/10.1002/oby.24002
  6. Zeyu Xie, Guimei Zheng, Zhuoru Liang, Mengting Li, Weishang Deng, Weiling Cao. Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials. Metabolism 2024;161:156038
    https://doi.org/10.1016/j.metabol.2024.156038
  7. Mark A. Moyad. Embracing the Pros and Cons of the New Weight Loss Medications (Semaglutide, Tirzepatide, Etc.). Curr Urol Rep 2023;24:515
    https://doi.org/10.1007/s11934-023-01180-7
  8. Jee-Hyun Kang, Kyoung-Kon Kim. Guidelines for obesity clinic consultations in primary healthcare clinics. J Korean Med Assoc 2024;67:240
    https://doi.org/10.5124/jkma.2024.67.4.240
  9. Rieko Kanai, Sachiho Kinoshita, Izumi Kanbe, Mariko Sameda, Shuhei Yamaoka, Osamu Horikawa, Yasuhiro Watanabe, Ichiro Tatsuno, Kohji Shirai, Takashi Oshiro, Atsuhito Saiki. Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes. Obesity Pillars 2024;9:100098
    https://doi.org/10.1016/j.obpill.2023.100098
  10. Maurizio De Luca, Amanda Belluzzi, Paulina Salminen, Marco Bueter, Juan Pujol-Rafols, Nasser Sakran, Christine Stier, Halit Eren Taskin, Sonja Chiappetta, Francesco Maria Carrano, Nicola Di Lorenzo, Simon Nienhuijs, Ramón Vilallonga Puy, Erik Stenberg, Marloes Emous, Gerhard Prager, Jacques Himpens, Daniel Moritz Felsenreich, Antonio Iannelli, Chetan Parmar, Catalin Copaescu, Martin Fried, Elena Ruiz-Úcar, Ricardo V. Cohen, Stefano Olmi, Luigi Angrisani, Rui Ribeiro, Giulia Bandini, Daniele Scoccimarro, Benedetta Ragghianti, Matteo Monami. Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects. JCM 2024;13:5106
    https://doi.org/10.3390/jcm13175106
  11. Young Lyu, Hongyup Ahn, Sangmo Hong, Cheol-Young Park. Safety and Effectiveness of Naltrexone-Bupropion in Korean Adults with Obesity: Post-Marketing Surveillance Study. DDDT 2024;Volume 18:5255
    https://doi.org/10.2147/DDDT.S492913
  12. Anuj Panchal, Anjali Khantal. A Review on Pharmacological and Non-Pharmacological Therapy for the treatment of Obesity with Cardiovascular Diseases. RJPPD 2024:114
    https://doi.org/10.52711/2321-5836.2024.00020
  13. Arya M. Sharma. The Transformative Impact of New Anti-Obesity Medications: A Paradigm Shift in Medical Practice?. Journal of Obesity & Metabolic Syndrome 2023;32:285
    https://doi.org/10.7570/jomes23078